Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Short-term Investments (2016 - 2021)

Aytu Biopharma (AYTU) has disclosed Short-term Investments for 6 consecutive years, with $252000.0 as the latest value for Q3 2021.

  • Quarterly Short-term Investments changed 0.0% to $252000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $252000.0 through Sep 2021, changed 0.0% year-over-year, with the annual reading at $252000.0 for FY2021, 0.4% changed from the prior year.
  • Short-term Investments for Q3 2021 was $252000.0 at Aytu Biopharma, roughly flat from $252000.0 in the prior quarter.
  • The five-year high for Short-term Investments was $252000.0 in Q3 2020, with the low at $75214.0 in Q2 2017.
  • Average Short-term Investments over 5 years is $195549.0, with a median of $250500.0 recorded in 2019.
  • The sharpest move saw Short-term Investments crashed 92.78% in 2017, then soared 150.83% in 2019.
  • Over 5 years, Short-term Investments stood at $75214.0 in 2017, then surged by 33.25% to $100225.0 in 2018, then skyrocketed by 150.83% to $251396.0 in 2019, then grew by 0.24% to $252000.0 in 2020, then changed by 0.0% to $252000.0 in 2021.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $252000.0, $252000.0, and $252000.0 for Q3 2021, Q2 2021, and Q4 2020 respectively.